Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2023-05-24 00:00:00 ET · period of report 2023-05-22 · accession 0001209191-23-031874 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-24 | 2023-05-22 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $10.12 | -10.3K | 321.1K | -3% | -$104.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-05-22 | S | D | 10,324 | $10.12 | 321,131 | D | — | — |